Duke medical team creates, implants bioengineered vein

06/9/2013 | American City Business Journals · Nature World News

Duke University physicians have successfully fashioned a bioengineered vein and implanted it into the arm of a patient with end-stage renal disease in the nation's first clinical trial of its kind. The vessel was grown from donated human blood cells on a scaffold and carries no risk of rejection. "We hope this sets the groundwork for how these things can be grown, how they can incorporate into the host and how they can avoid being rejected immunologically," said Dr. Jeffrey H. Lawson. "A blood vessel is really an organ -- it's complex tissue. We start with this, and one day we may be able to engineer a liver or a kidney or an eye."

View Full Article in:

American City Business Journals · Nature World News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN